• 99% API High Purity Treat Leukemia CAS 220127-57-1 Imatinib Mesylate
  • 99% API High Purity Treat Leukemia CAS 220127-57-1 Imatinib Mesylate
  • 99% API High Purity Treat Leukemia CAS 220127-57-1 Imatinib Mesylate
  • 99% API High Purity Treat Leukemia CAS 220127-57-1 Imatinib Mesylate
  • 99% API High Purity Treat Leukemia CAS 220127-57-1 Imatinib Mesylate
  • 99% API High Purity Treat Leukemia CAS 220127-57-1 Imatinib Mesylate

99% API High Purity Treat Leukemia CAS 220127-57-1 Imatinib Mesylate

Powder: Yes
Customized: Non-Customized
Certification: GMP, HSE, ISO 9001, USP, BP
Suitable for: Elderly, Children, Adult
State: Powder
Purity: >99%
Samples:
US$ 25/kg 1 kg(Min.Order)
| Request Sample
Customization:
Gold Member Since 2022

Suppliers with verified business licenses

Manufacturer/Factory
  • Overview
  • Product Description
  • Function
  • Related Product
  • Packaging & Shipping
Overview

Basic Info.

Model NO.
HMJ- Imatinib mesylate
Color
White
Mf
C30h35n7o4s
Einecs
606-892-3
Test
HPLC
MW
589.71
CAS
220127-57-1
Shelf Life
2 Years
Grade
Pharmaceutical Grade
Transport Package
Ziplock Foil Bag. Drum
Specification
1kg Per Foil Bag, 10 Bags Per Carton, 25 Kg Per Dr
Trademark
HMJ
Origin
China
Production Capacity
200kg/Month

Product Description

99% API High Purity Treat Leukemia Cas 220127-57-1 Imatinib mesylate
99% API High Purity Treat Leukemia CAS 220127-57-1 Imatinib Mesylate
Product Description

 

Product Name  Imatinib Mesylate
Appearance White powder
Molecular formula C30H35N7O4S
Molecular weight  589.71
Keywords Powder Imatinib Mesylate,Price Imatinib Mesylate; Pure Imatinib Mesylate
Shelf Life 24 months when properly stored
Storage Keep in a cool, dry, dark location
Function

What is Imatinib Mesylate?

Imatinib is a Kinase Inhibitor. The mechanism of action of imatinib is as a Protein Kinase Inhibitor.
 Imatinib, sold under the brand names Gleevec among others, is a chemotherapy medication used to treat cancer. Specifically, it is used for chronic myelogenous leukemia (CML) and acute lymphocytic leukemia (ALL) that is Philadelphia chromosome-positive (Ph+) and certain types of gastrointestinal stromal tumors (GIST), systemic mastocytosis, and myelodysplastic syndrome. It is taken by mouth.

 

Function of Imatinib Mesylate

Imatinib can be used for the treatment of the chronic myelogenous leukemia (abbreviated CML) of positive symptoms of Philadelphia chromosome (Ber-Abl). It is suitable for being applied to adult patients in acute transformation phase, accelerated phase, and chronic phase with treatment failure with interferon.

 

Related Product

99% API High Purity Treat Leukemia CAS 220127-57-1 Imatinib Mesylate

Packaging & Shipping


99% API High Purity Treat Leukemia CAS 220127-57-1 Imatinib Mesylate

 

99% API High Purity Treat Leukemia CAS 220127-57-1 Imatinib Mesylate99% API High Purity Treat Leukemia CAS 220127-57-1 Imatinib Mesylate99% API High Purity Treat Leukemia CAS 220127-57-1 Imatinib Mesylate99% API High Purity Treat Leukemia CAS 220127-57-1 Imatinib Mesylate

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now